The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: olanzapine     Quarter: 2016Q3

Total Drug/Injury Combinations: 887     Number of Pages: 45

DRUGNAME PT EventCount
OLANZAPINE. Visual acuity reduced 1 view events
OLANZAPINE. Vocal cord disorder 1 view events
OLANZAPINE. Vulval cancer 1 view events
OLANZAPINE/ WFLUOXETINE Drug interaction 1 view events
OLANZAPINE/ WFLUOXETINE Nausea 1 view events
OLANZAPINE/ WFLUOXETINE Neuroleptic malignant syndrome 1 view events
OLANZAPINE/ WFLUOXETINE Serotonin syndrome 1 view events

Total Drug/Injury Combinations: 887     Number of Pages: 45

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)